Consent to the Distribution of New Medicines Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution inNew Zealand of the new medicines set out in the Schedule hereto: Schedule Name and Strength Form Name and Address of Manufacturer Proprietary Name(if any) Baclofen 10 mg, 20 mg Tablets Apotex Inc., Weston, Ontario, Canada Apo-Baclofen Bromocriptine mesylate 2.5 mg Tablets Apotex Inc., Weston, Ontario, Canada Apo-Bromocriptine Betamethasone valerate 0.12% w/w equivalent to 0.1% w/w betamethasone in 30 g, 100 g Ointment, skin Douglas Pharmaceuticals Limited, Mount Wellington, Auckland, New Zealand Betamethasone Betamethasone valerate 0.12% w/w equivalent to 0.1% w/w betamethasone in 30 g, 100 g Cream, skin Douglas Pharmaceuticals Limited, Mount Wellington, Auckland, New Zealand Betamethasone Nadroparin calcium 9,500 anti-Xa IU per mL in 0.2 mL, 0.3 mL, 0.4 mL, 0.6 mL, 0.8 mL, 1 mL Injection, prefilled syringe Sanofi Winthrop Industrie, Notre Dame de Bondeville, France Fraxiparine Polyethylene glycol 4000 60 g in 1 L Solution, oral McGaw Biomed Limited, Point Chevalier, Auckland Gut Lavage Solution Lodoxamide trometamol 1.78 mg/mL equivalent to 1 mg/mL lodoxamide in 5 mL, 10 mL Eye drops S A Alcon Couvreur N V., Puurs, Belgium Lomide Sodium phenytoin 100 mg in 2 mL, 250 mg in 5 mL Injection David Bull Laboratories Limited, Mulgrave North, Victoria, Australia Phenytoin Permethrin 5% w/v in 50 mL, 100 mL Lotion, skin Stafford Miller Limited, Padstow, New South Wales, Australia Quellada-P Vancomycin hydrochloride 500 mg, 1 g Injection, powder (vial) Abbott France, Saint Remy-sur-Avre, France Vancomycin Hydrochloride for Injection Dated this 17th day of July 1996. HUGH BABER, Assistant General Manager, Health Regulation and Protection, pursuant to delegation given by the Minister of Health on the 18th day of January 1996.